ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

In Brief: Beatrice Mintz Appointed to Pontifical Academy; Three Americans Asked to Help Shanghai Group

November 28, 1986

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued

May 16, 1980

Nurse Participation In International Congress Increases

September 19, 1986

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983